Inhalable drugs

[sportsrancho]

www.prnewswire.co.uk/news-releases/inhalable-drugs-market-size-to-hit-us-41-5-billion-by-2026-822172294.html

Major players are also moving into new regions or advanced technologies. For instance, MannKind Corporation developed and commercialized FDA approved Afrezza, an inhalation powder for diabetes patients in 2019.

[mnkdfann]

In 2019, you (they) say?

[nylefty]

Jan 16, 2020 21:11:41 GMT -5 sportsrancho said:

www.prnewswire.co.uk/news-releases/inhalable-drugs-market-size-to-hit-us-41-5-billion-by-2026-822172294.html

Major players are also moving into new regions or advanced technologies. For instance, MannKind Corporation developed and commercialized FDA approved Afrezza, an inhalation powder for diabetes patients in 2019.

Seems like only yesterday.

[sportsrancho]

Jan 16, 2020 21:37:10 GMT -5 mnkdfann said:

In 2019, you (they) say?

They say🤷‍♀️

[mnholdem]

Stay timed... 

[ktim]

These script numbers and formulary coverage are GREAT for a drug so recently introduced to the market. I hope management got a big year end bonus.

[cretin11]

Jan 17, 2020 16:09:50 GMT -5 ktim said:

These script numbers and formulary coverage are GREAT for a drug so recently introduced to the market. I hope management got a big year end bonus.

Typical ktim, always overly optimistic and so easily pleased.    I would say the script numbers and formulary coverage are ok at best for a drug introduced in 2019.  But not horrible at least.

Actually, I should restate that:  if the drug was introduced in January of 2019 then the numbers aren't great.  But if it was introduced in December 2109, then yes I agree GREAT numbers!